Kezar Life Sciences, Inc. (KZR), a clinical-stage biotechnology company discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer, today announced that John Fowler, Chief Executive Officer, will present at The BMO Prescriptions for Success Healthcare Conference on December 12, 2018, at 10:00 am EST.
The presentation will be webcast and may be accessed at the “Events & Presentations” section of the Company’s website at http://investors.kezarlifesciences.com/events. Kezar Life Sciences will maintain an archived replay of the webcast on its website for 30 days after the conference.
https://finance.yahoo.com/news/kezar-life-sciences-present-bmo-130000372.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.